We are excited to announce GreenLight Clinical (GLC) new logo as part of our company’s continuous growth.
We are rebranding to reflect our evolution and commitment to innovation in the healthcare research industry. Our new logo symbolizes our unwavering dedication to progress, sustainability, and excellence in clinical research and providing new healthcare solutions.
Over the years we have developed and advanced since our beginning in 2015, and now is the ideal opportunity for a change. With this rebrand, we are signalling a fresh chapter of growth, reflecting our agility and adaptability in meeting the ever-changing needs of our clients and patients.
Emerging from the company’s commitment to continuous innovation and excellence in clinical research, GLC’s new logo demonstrates modernity and simplicity. This design is reflective our approach to clinical trials, modern and innovative solutions. This subtle yet impactful change represents GLC’s dynamic nature and its adaptability to the changing landscape of clinical research.
The new logo retains elements of the previous design, ensuring a seamless transition that current and partners and sponsors will recognize. GLC has provided a compelling ‘before and after’ comparison image to showcase the transformation.
Our main objective was to keep the logo identifiable and aligned with our greater group of companies such as Acurio Group. In order to achieve this result, we carefully reworked the existing logo, taking into account its basic shapes, angles, and colours.
GLC will be rolling out the updated logo across all channels over the coming months. Communication materials, digital platforms, and corporate merchandise will display the refreshed branding. We understand that modifying our logo is a practice that can entail many steps & require some time, so we will do so in stages.
GreenLight Clinical is a full-service Clinical Contract Research Organisation (CRO) that passionately upholds the highest standards of quality throughout from Phase I to Phase III of clinical trials. Our footprint expands globally from Australia, to include the vibrant US and Asia Pacific regions. Combining medical expertise and deep industry knowledge, we develop bespoke solutions to accelerate your innovative treatment development for patients with unmet needs.
